{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:14:23Z","timestamp":1783350863928,"version":"3.54.6"},"reference-count":37,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Medical Science and Technology Research Program of Chongqing Banan Science and Technology Bureau and Chongqing Banan Health Commission","award":["BNWJ202619"],"award-info":[{"award-number":["BNWJ202619"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: The incremental value of iodine-125 (I-125) seed implantation in advanced refractory lung squamous cell carcinoma (LUSC) with hemoptysis treated with bronchial artery chemoembolization (BACE) and immunotherapy remains unclear. Methods: This retrospective cohort study included 90 patients treated between June 2023 and June 2025. Patients receiving BACE plus immunotherapy were classified according to whether I-125 seed implantation was performed within 7 days after BACE: G1, BACE plus immunotherapy (n = 42), and G2, BACE, I-125 seed implantation, and immunotherapy (n = 48). Inverse probability of treatment weighting (IPTW) served as the primary adjustment method. Results: After IPTW, baseline covariates were well balanced; propensity score matching yielded 26 patients per group. Compared with G1, G2 was associated with longer hemoptysis-free survival (not reached vs. 11 months; HR = 0.34, 95% CI 0.18\u20130.64, p &lt; 0.05), overall survival (19 vs. 14 months; HR = 0.26, 95% CI 0.15\u20130.44, p &lt; 0.05), and progression-free survival (12 vs. 9 months; HR = 0.34, 95% CI 0.21\u20130.56, p &lt; 0.05). The 6-month objective response rate (ORR) and disease control rate (DCR) were higher in G2, whereas no significant difference in 24-h hemostasis or recorded grade 3 or higher adverse events was observed. Conclusions: Adding I-125 seed implantation to BACE plus immunotherapy was associated with improved outcomes in selected patients, and prospective validation is warranted.<\/jats:p>","DOI":"10.3390\/curroncol33070402","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:01:37Z","timestamp":1783339297000},"page":"402","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incremental Value of Iodine-125 Seed Implantation After Bronchial Artery Chemoembolization in Immunotherapy-Treated Advanced Lung Squamous Cell Carcinoma with Hemoptysis: A Retrospective Cohort Study Using Inverse Probability of Treatment Weighting"],"prefix":"10.3390","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3689-6832","authenticated-orcid":false,"given":"Linhao","family":"Ran","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Banan Hospital of Chongqing Medical University, Chongqing 401320, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Banan Hospital of Chongqing Medical University, Chongqing 401320, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Banan Hospital of Chongqing Medical University, Chongqing 401320, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajian","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Banan Hospital of Chongqing Medical University, Chongqing 401320, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichen","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Banan Hospital of Chongqing Medical University, Chongqing 401320, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dichun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Banan Hospital of Chongqing Medical University, Chongqing 401320, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Banan Hospital of Chongqing Medical University, Chongqing 401320, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Banan Hospital of Chongqing Medical University, Chongqing 401320, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Banan Hospital of Chongqing Medical University, Chongqing 401320, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer","volume":"379","author":"Luft","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_3","first-page":"371","article-title":"The diagnosis and treatment of hemoptysis","volume":"114","author":"Ittrich","year":"2017","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"111786","DOI":"10.1016\/j.ejrad.2024.111786","article-title":"Non-emergent hemoptysis in patients with primary or metastatic lung tumors: The role of transarterial embolization","volume":"181","author":"Geevarghese","year":"2024","journal-title":"Eur. J. Radiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.55730\/1300-0144.5534","article-title":"Management of recurrent hemoptysis: A single-center experience","volume":"52","author":"Onur","year":"2022","journal-title":"Turk. J. Med. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2217\/fon-2021-1515","article-title":"Efficacy and safety of drug-eluting beads bronchial arterial chemoembolization versus conventional bronchial arterial chemoembolization in lung cancer patients with hemoptysis","volume":"18","author":"Fu","year":"2022","journal-title":"Future Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jvir.2018.08.022","article-title":"Bronchial artery embolization for hemoptysis in primary lung cancer: A retrospective review of 84 patients","volume":"30","author":"Han","year":"2019","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.jvir.2024.05.017","article-title":"Predictive factors for recurrent hemoptysis after bronchial artery embolization in patients with lung cancer","volume":"35","author":"Hanotin","year":"2024","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5152\/dir.2017.16454","article-title":"Bronchial artery embolization in hemoptysis: A systematic review","volume":"23","author":"Panda","year":"2017","journal-title":"Diagn. Interv. Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Li, R., Liang, H., Li, J., Shao, Z., Yang, D., Bao, J., Wang, K., Xi, W., Gao, Z., and Guo, R. (2024). (Paclitaxel liposome (lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: A multicenter, retrospective real-world study. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-11860-3"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.lungcan.2020.06.010","article-title":"Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy","volume":"146","author":"Chen","year":"2020","journal-title":"Lung Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e29251","DOI":"10.1097\/MD.0000000000029251","article-title":"To evaluate the efficacy and safety of 125I seed implantation in SCLC as second line therapy","volume":"101","author":"Cheng","year":"2022","journal-title":"Medicine"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Li, R., Zhang, Y., Yuan, Y., Lin, Q., Dai, J., Xu, R., Hu, X., and Han, M. (2017). Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187390"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5114\/jcb.2021.109789","article-title":"A machine-learning approach based on 409 treatments to predict optimal number of iodine-125 seeds in low-dose-rate prostate brachytherapy","volume":"13","author":"Boussion","year":"2021","journal-title":"J. Contemp. Brachytherapy"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1038\/s41598-022-15028-6","article-title":"Comparative effectiveness of low-dose-rate brachytherapy with or without external beam radiotherapy in favorable and unfavorable intermediate-risk prostate cancer","volume":"12","author":"Tsumura","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13014-022-02196-y","article-title":"Efficacy and toxicity of iodine-125 seed implantation for lymph node recurrence secondary to esophageal cancer after radiotherapy: A multicenter retrospective study","volume":"18","author":"Wu","year":"2023","journal-title":"Radiat. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"112295","DOI":"10.1016\/j.ejrad.2025.112295","article-title":"Evaluating the efficacy of 8Spheres microsphere combined with iodine-125 seeds in the treatment of advanced lung squamous cell carcinoma presenting with hemoptysis: A retrospective study","volume":"191","author":"Ran","year":"2025","journal-title":"Eur. J. Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.6004\/jnccn.2017.0050","article-title":"Non-small cell lung cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Ettinger","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110747","DOI":"10.1016\/j.ejrad.2023.110747","article-title":"Bronchial artery chemoembolization with drug-eluting beads versus bronchial artery infusion followed by polyvinyl alcohol particles embolization for advanced squamous cell lung cancer: A retrospective study","volume":"161","author":"He","year":"2023","journal-title":"Eur. J. Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"n2363","DOI":"10.1136\/bmj.n2363","article-title":"Advances in systemic therapy for non-small cell lung cancer","volume":"375","author":"Miller","year":"2021","journal-title":"BMJ"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung Cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.21037\/apm-24-45","article-title":"Effectiveness of palliative hemostatic radiotherapy for hemoptysis: A prospective single-arm observation study","volume":"13","author":"Aljabab","year":"2024","journal-title":"Ann. Palliat. Med."},{"key":"ref_24","first-page":"386","article-title":"Brachytherapy: An overview for clinicians","volume":"69","author":"Chargari","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5114\/jcb.2017.72607","article-title":"Current status of brachytherapy in cancer treatment\u2014Short overview","volume":"9","author":"Skowronek","year":"2017","journal-title":"J. Contemp. Brachytherapy"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhang, T., Mo, Z., Duan, G., Tang, R., Zhang, F., and Lu, M. (2021). 125I seed promotes apoptosis in non-small lung cancer cells via the p38 MAPK-MDM2-p53 signaling pathway. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.582511"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.brachy.2020.02.009","article-title":"Dosimetry, efficacy, and safety of three-dimensional printing noncoplanar template-assisted and CT-guided 125I seed implantation for recurrent retroperitoneal lymphatic metastasis after external beam radiotherapy","volume":"19","author":"Chen","year":"2020","journal-title":"Brachytherapy"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.2013.53.4115","article-title":"Impact of brachytherapy on local recurrence rates after sublobar resection: Results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer","volume":"32","author":"Fernando","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_29","first-page":"2554","article-title":"Drug-eluting bead bronchial arterial vhemoembolization vs. vhemotherapy in treating advanced non-small cell lung cancer: Comparison of treatment efficacy, safety and quality of life","volume":"25","author":"Liu","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ma, X., Zheng, D., Zhang, J., Dong, Y., Li, L., Jie, B., and Jiang, S. (2022). Clinical outcomes of vinorelbine loading CalliSpheres beads in the treatment of previously treated advanced lung cancer with progressive refractory obstructive atelectasis. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.1088274"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.21037\/jtd-23-1635","article-title":"The efficacy and safety of percutaneous CT-guided iodine-125 brachytherapy combined with standard chemotherapy and brachytherapy alone for lung malignant nodule: A retrospective comparative cohort study","volume":"16","author":"Tang","year":"2024","journal-title":"J. Thorac. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2213-2600(20)30391-X","article-title":"Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: A pooled analysis of two randomised trials","volume":"9","author":"Theelen","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(21)00630-6","article-title":"Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): Interim results of a randomised, double-blind, multicentre, phase 3 trial","volume":"23","author":"Zhou","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The cytosolic DNA-sensing cGAS-STING pathway in cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and Anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1172\/JCI96582","article-title":"Increased vessel perfusion predicts the efficacy of immune checkpoint blockade","volume":"128","author":"Zheng","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.clinthera.2020.05.018","article-title":"Clinical application of iodine-125 seed brachytherapy combined with Anti-PD-1 antibodies in the treatment of lung cancer","volume":"42","author":"Sui","year":"2020","journal-title":"Clin. Ther."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/7\/402\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:15:47Z","timestamp":1783347347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/7\/402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,5]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["curroncol33070402"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33070402","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,5]]}}}